Emory University v Biochem Pharma Inc

Link copied
Case Copied 25 min read

official notice

decision of a deputy commissioner of patents

Patent Application               :          658136 in the name of Emory University

Title:          Method and compositions for the synthesis of BCH-189 and related compounds

Action:          Opposition by Biochem Pharma Inc, a notice under s.210(c) requiring Biochem Pharma Inc produce 17 documents, and in the matter of lawful excuse.

Decision:          Issued            .

Abstract

The Commissioner issued a notice requiring Biochem Pharma Inc to produce 17 documents. Biochem Pharma Inc claimed lawful excuse for not producing the documents. Those documents had been identified as a result of discovery proceedings in the USA, and Emory had obtained leave from a US Court to put them before the Commissioner, conditional upon the Commissioner considering the documents in confidence.

1.   The opponent acceded to the jurisdiction of the Commissioner to require production of the documents (which were not located in Australia).

2.   No-one at the hearing had constructive knowledge of the content of the documents. Hence relevance could only be assessed on an 'adjectival' basis.

3.   While evidence of the notional person skilled in the art in Australia is paramount for a number of issues, the credibility of such evidence may properly be assessed by having regard to what happened elsewhere.

4.   While Biochem Pharma Inc suggest that the 17 documents would be taken out of context, the mere reference to there having been 400,000 pages of documents discovered was insufficient to show that it would be onerous to provide context.

5.   While the production will inevitably delay the proceedings, in the present case such delay was not counter to the public interest.

6.   Where the Commissioner invoked Regulation 4.3(2)(b), both the documents produced, and any other copy of those documents filed (such as in evidence) are prescribed documents for the purpose of s.55 of the Patents Act.

§  Upon production of the documents, the Commissioner would invoke regulation 4.3(2)(b). As a result, the documents produced would be maintained confidential before the Commissioner.

§ If Biochem Pharma Inc is correct in asserting that documents produced are not thereby filed, then any copies of the documents filed in evidence would still be prescribed documents for the purpose of s.55 of the Act. In the present case, the copy produced to the Commissioner would be an exempt document under s.45 of the Freedom of Information Act 1982. Accordingly, both the produced copy, and any copies served in evidence, would be maintained confidential before the Commissioner.

7.   Biochem Pharma Inc had not established any lawful excuse for not producing the documents, and was given 28 days to produce the documents. Since no-one at the hearing had constructive knowledge of the content of the documents, the Commissioner is prepared to reconsider the question of relevance based on the actual content of the documents.

patents act 1990

decision of a deputy commissioner of patents

Re:658136 in the name of Emory University, opposition by Biochem Pharma Inc, a notice under s.210(c) requiring Biochem Pharma Inc produce 17 documents,…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Emory University v Biochem Pharma Inc and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[1998] APO 50
Decision Date

CaseChat Overview and Summary

The Commissioner of Patents issued a notice under s.210(c) of the Patents Act 1990 requiring Biochem Pharma Inc to produce 17 documents in relation to a patent application by Emory University. Biochem Pharma Inc claimed a lawful excuse for not producing the documents and the Commissioner, D Herald, heard the matter. The Commissioner found that Biochem Pharma Inc had not established any lawful excuse for not producing the documents and was given 28 days to produce the documents. The Commissioner also indicated that he would reconsider the question of relevance based on the actual content of the documents. The Commissioner found that the Commissioner had jurisdiction to require the production of the documents, the documents were relevant, and the documents could be maintained confidential before the Commissioner. The Commissioner awarded costs of the hearing against Biochem Pharma Inc.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.